Eli Lilly and Company LLY Announces 23B Planned Acquisition of Ajax Therapeutics to Bolster Hematological Oncology Pipeline DRTS Alpha Tau posts narrower than expected Q4 2025 loss shares gain 138 percent in todays trading FRD Friedman Industries stock gains 414 percent following the release of its Q3 2024 earnings report